Exploring Transcriptomic and Immunopeptidome Heterogeneity in Brain Tumor Models for Downstream Targeted Immunotherapies

Time: 11:45 am
day: Day Two Track A AM


• Understanding the ramifications of these datasets for baseline mutations and neoepitope discovery

• Leveraging data from mass spectrometry to compare the in vivo peptidome with computational modelling from sequencing